Lesson Learned in Drug Development for Year Ahead

ABSTRACT

COVID-19 highlighted the value of remote approaches in many fields, but DCTs offered an opportunity beyond the needs of the pandemic to make clinical research easier for patients to participate in and more accessible to a wider population not served by traditional study design. Partnership-driven approach to working with communities and patient advocacy groups As part of their efforts to increase diversity and equity in clinical research, organizations have changed how they work with patients by fostering closer partnerships with communities and patient advocacy groups. A 2021 survey by the Center for Information and Study on Clinical Research Participation found that, while overall awareness of research had increased, self-reported understanding of clinical trials and willingness to participate has decreased since 2019.